NEW YORK (
CHANGE IN RATINGS
upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $68 price target. Company has superior cyclical earnings power.
Beneficial Mutual Bancorp
upgraded to buy at TheStreet Ratings.
(BRCD - Get Report)
rated new Neutral at Sterne Agee. Valuation call, as the company is still in the early stages of a growth turnaround.
Buffalo Wild Wings
upgraded at Wedbush from Neutral to Outperform, Wedbush said. $100 price target. Menu prices are higher but wing costs have remained stable.
downgraded at KBW to Market Perform, Keefe, Bruyette & Woods said. $12.50 price target. Company should see muted near-term earnings growth.
Central Pacific Financial
upgraded to hold at TheStreet Ratings.
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. New analyst has a $55 price target.
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $81 price target. New analyst believes that the new management team can improve the company's earnings power.
upgraded at Baird from Neutral to Outperform, Robert Baird said. $38 price target. Valuation call, as the stock has pulled back 17% since July.
downgraded at Keybanc from Buy to Hold, Keybanc said. Estimates also cut, given lower demand for drilling pumps.
(HPQ - Get Report)
downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Company faces both secular and structural headwinds.
upgraded at Baird to Buy, Robert Baird said. $33 price target. Stock is attractive to buy, following a 23% selloff.
(MAR - Get Report)
downgraded at Lazard from Buy to Neutral, Lazard said. Estimates also cut, as the company is realizing lower RevPAR growth.
Marriot downgraded at UBS to Neutral from Buy, UBS said. $42 price target. Valuation call, remain positive on lodging recovery.
rated new Market Perform at BMO. $33 price target. Stock is already pricing in strong expected growth.
downgraded at Goldman to Neutral, Goldman Sachs said. Company is leveraged to lower bleached board prices. $30 price target.
upgraded at Goldman to Buy, Goldman Sachs said. $28 price target. New CFO is improving the company's capital allocation strategy.